Table 1.
Patients and treatment characteristics
| Factors | N | % |
|---|---|---|
| Age | ||
| < 60 y | 54 | 42.9 |
| > 60 y | 72 | 57.1 |
| Lymphadenectomy | ||
| None | 18 | 14.3 |
| Sampling* | 14 | 11.1 |
| Systematic** | 79 | 62.7 |
| Not available | 15 | 11.9 |
| FIGO group | ||
| IAG1 | 7 | 5.6 |
| IAG2 | 46 | 36.5 |
| IAG3 | 34 | 27 |
| IBG1 | 14 | 11.1 |
| IBG2 | 21 | 16.7 |
| IBG3 | 3 | 2.4 |
| IIAG2 | 1 | 0.8 |
| Isthmus involvement | ||
| Negative | 107 | 84.9 |
| Positive | 19 | 15.1 |
| Angiolimphatic invasion | ||
| Negative | 118 | 93.7 |
| Positive | 8 | 6.3 |
*
Sampling: less than 12 lymph nodes removed.
**
Systematic: 12 or more lymph nodes removed. FIGO 2009 staging